Showing results (21-30 of 131) with videos related to
Sort By:
Pageof 14
The Oncologist|May 25, 2010
Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choicesYu-Ning Wong, Olivia Hamilton, Brian Egleston, et al.Medical Care|May 25, 2013
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score WorkSteven R Austin, Yu-Ning Wong, Robert G Uzzo, et al.Cancer|July 1, 2011
Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer careKaryn B Stitzenberg, Yu-Ning Wong, Matthew E Nielsen, et al.Journal of Biomedical Informatics|June 6, 2009
Integration of prostate cancer clinical data using an ontologyHua Min, Frank J Manion, Elizabeth Goralczyk, et al.Cancer|July 6, 2016
Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancerNamrata Vijayvergia, Tianyu Li, Yu-Ning Wong, et al.Medical Care|October 19, 2011
Racial disparities in changing to a high-volume urologist among men with localized prostate cancerCraig Evan Pollack, Justin E Bekelman, Andrew J Epstein, et al.Journal of Oncology Practice|July 24, 2014
Oncologists' response to new data regarding the use of epidermal growth factor receptor inhibitors in colorectal cancerEfrat Dotan, Tianyu Li, Michael J Hall, et al.Cancer|March 25, 2009
Cost implications of new treatments for advanced colorectal cancerYu-Ning Wong, Neal J Meropol, William Speier, et al.Urologic Oncology|September 9, 2008
Predicting growth of solid renal masses under active surveillancePaul L Crispen, Yu-Ning Wong, Richard E Greenberg, et al.The Journal of Urology|October 23, 2012
Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based modelAlexander Kutikov, Brian L Egleston, Daniel Canter, et al.Pageof 14